Skip to main content
Fig. 1 | Cell Division

Fig. 1

From: YAP1 activates SLC2A1 transcription and augments the malignant behavior of colorectal cancer cells by activating the Wnt/β-catenin signaling pathway

Fig. 1

Elevated SLC2A1 levels in CRC.AC Volcano plots for DEGs in GSE14297, GSE18462, and GSE40367 datasets; D Venn diagram of intersecting DEGs from GSE14297, GSE18462, and GSE40367; E Comparison of SLC2A1 levels in TCGA-COAD and normal colon tissues from the GTEx database; F Kaplan-Meier analysis of SLC2A1 levels in relation to patient survival in the TCGA-COAD database, Cut-off = SLC2A1 median; G SLC2A1 levels in patients with different clinical stages in the TCGA-COAD database; HI qPCR and WB analyses of SLC2A1 levels in COAD cell lines Caco-2, HCT116, SW480, and immortalized colonic mucosal cell line FHC. Cell experiments were repeated 3–5 times, with statistical analysis performed using One-Way ANOVA, **P < 0.01

Back to article page